Gene · 5313
Papers2,223
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
441 to 460 of 2,223
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Targeting HIF-1α by Natural and Synthetic Compounds: A Promising Approach for Anti-Cancer Therapeutics Development. | Molecules | 2022 | 36014432 | PubTator, text mining | PubMed |
| Genomic Analyses of Non-Coding RNAs Overlapping Transposable Elements and Its Implication to Human Diseases. | Int J Mol Sci | 2022 | 36012216 | PubTator, text mining | PubMed |
| Therapeutic Strategies in Huntington's Disease: From Genetic Defect to Gene Therapy. | Biomedicines | 2022 | 36009443 | PubTator, text mining | PubMed |
| A genome sequencing system for universal newborn screening, diagnosis, and precision medicine for severe genetic diseases. | Am J Hum Genet | 2022 | 36007526 | PubTator, text mining | PubMed |
| The Role of Protein Kinase CK2 in Development and Disease Progression: A Critical Review. | J Dev Biol | 2022 | 35997395 | PubTator, text mining | PubMed |
| β-cell deletion of the PKm1 and PKm2 isoforms of pyruvate kinase in mice reveals their essential role as nutrient sensors for the KATP channel. | Elife | 2022 | 35997256 | PubTator, text mining | PubMed |
| Associations of Mitochondrial Function, Stress, and Neurodevelopmental Outcomes in Early Life: A Systematic Review. | Dev Neurosci | 2022 | 35995037 | PubTator, text mining | PubMed |
| Metastatic triple negative breast cancer adapts its metabolism to destination tissues while retaining key metabolic signatures. | Proc Natl Acad Sci U S A | 2022 | 35994654 | PubTator, text mining | PubMed |
| Discovery of therapeutic agents targeting PKLR for NAFLD using drug repositioning. | EBioMedicine | 2022 | 35988463 | PubTator, text mining | PubMed |
| DDX39B drives colorectal cancer progression by promoting the stability and nuclear translocation of PKM2. | Signal Transduct Target Ther | 2022 | 35973989 | PubTator, text mining | PubMed |
| Research progress on the role of PKM2 in the immune response. | Front Immunol | 2022 | 35967360 | PubTator, text mining | PubMed |
| The Microenvironment That Regulates Vascular Wall Stem/Progenitor Cells in Vascular Injury and Repair. | Biomed Res Int | 2022 | 35958825 | PubTator, text mining | PubMed |
| Molecular mechanisms underlying the role of hypoxia-inducible factor-1 α in metabolic reprogramming in renal fibrosis. | Front Endocrinol (Lausanne) | 2022 | 35957825 | PubTator, text mining | PubMed |
| The Genomic 3' UTR of Flaviviruses Is a Translation Initiation Enhancer. | Int J Mol Sci | 2022 | 35955738 | PubTator, text mining | PubMed |
| Parametric Effects of Fused Filament Fabrication Approach on Surface Roughness of Acrylonitrile Butadiene Styrene and Nylon-6 Polymer. | Materials (Basel) | 2022 | 35955141 | PubTator, text mining | PubMed |
| Balanced mitochondrial and cytosolic translatomes underlie the biogenesis of human respiratory complexes. | Genome Biol | 2022 | 35945592 | PubTator, text mining | PubMed |
| Altered macronutrient composition and genetics influence the complex transcriptional network associated with adiposity in the Collaborative Cross. | Genes Nutr | 2022 | 35945490 | PubTator, text mining | PubMed |
| TRABID targets DDB2 for deubiquitination to promote proliferation of hepatocellular carcinoma cells. | Biochem Biophys Res Commun | 2022 | 35944360 | PubTator, text mining | PubMed |
| Immunohistochemical Approach to Genetic Subtyping of Anaplastic Large Cell Lymphoma. | Am J Surg Pathol | 2022 | 35941721 | PubTator, text mining | PubMed |
| Comprehensive Analysis of Quantitative Proteomics With DIA Mass Spectrometry and ceRNA Network in Intrahepatic Cholestasis of Pregnancy. | Front Cell Dev Biol | 2022 | 35938169 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5313/papers?page=23